Mavrofrides Elias C MD is categorized under Ophthalmologists in Orlando, FL and active since 2007.
Mavrofrides Elias C MD was established in 2007, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Ophthalmologists business, which does work in the B2C market, and is classified as a Ophthalmologists, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Elias Mavrofrides at the company’s single location by writing to 4401 South Orange Avenue, Orlando, Florida FL 32806 or by phoning (407) 849-9621. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Mavrofrides Elias C MD |
| Contact Person: | Elias Mavrofrides |
| Address: | 4401 South Orange Avenue, Orlando, Florida 32806 |
| Phone Number: | (407) 849-9621 |
| Website Address: | floridaretinainstitute.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Ophthalmologists |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Mavrofrides Elias C MD was started in 2007 to provide professional Ophthalmologists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Elias Mavrofrides for inquiries that concern Mavrofrides Elias C MD by calling the company number (407) 849-9621, as your correspondence is most welcome. Additionally, the physical location of the single location of Mavrofrides Elias C MD can be found at the coordinates 28.49624,-81.37519 as well as the street address 4401 South Orange Avenue in Orlando, Florida 32806.
For its online presence, you may visit Mavrofrides Elias C MD’s website at floridaretinainstitute.com and engage with its social media outlets through on Twitter and on Facebook.